redwoodpharma.com
Japanese patent granted for IntelliGel platform - Redwood Pharma
http://redwoodpharma.com/japanese-patent-granted-intelligel-platform
Japanese patent granted for IntelliGel platform. August 30, 2016. The granting of a Japanese patent for the IntelliGel platform opens a significant global market within ophthalmic medicines to Redwood Pharma. It is estimated that the total Japanese market in 2014 for prescription ophthalmic medicines was valued at USD 3.2 billion [1]. Redwood Pharma has now strengthened its commercial possiblities to exploit this market. Says CEO Martin Vidaeus. Martin Vidaeus, CEO Redwood Pharma AB (publ.).
herslowpartners.se
Herslow & Partners · CORPORATE FINANCE & EXECUTIVE CONSULTING
http://www.herslowpartners.se/senaste
Investerarträff den 13 juni! Kommentarer inaktiverade för Investerarträff den 13 juni! Välkommen på investerarträff den 13 juni! Plats: Malmö Börshus, Skeppsbron 2. Tid: 17.30 ca 19.00. Vi erbjuder dig att träffa intressanta bolag. Här får du chansen att lyssna till och ställa dina frågor direkt till bolagets ledning. Många av bolagen är i ett tidigt skede och genomför en kapitalanskaffning Investerarträffen ger dig möjlighet att ta del av intressanta erbjudanden direkt från bolaget. PEN Concept Group AB.
brodatech.com
Broda Technologies - Breakthrough smart supramolecular drug delivery system, innovation
http://www.brodatech.com/innovation.html
Innovation - A Proprietary and Patented Smart Supramolecular Drug Delivery System. The effectiveness of medication depends on the method of administration. Treatments can often be improved by finding optimal drug formulations or delivery systems. Perhaps the only delivery system that can form a hydrogel at pH below 3. Proprietary Smart Supramolecular Drug Delivery System. Due to their unique complex structure formed by hydrophilic and hydrophobic chain segments, such materials can help dissolve water ins...
redwoodpharma.com
Development of Redwood Pharma’s RP101 ophthalmic therapy continues according to plan along with value-enhancing networking - Redwood Pharma
http://redwoodpharma.com/development-redwood-pharmas-rp101-ophthalmic-therapy-continues-according-plan-along-value-enhancing-networking
Development of Redwood Pharma’s RP101 ophthalmic therapy continues according to plan along with value-enhancing networking. December 21, 2016. In SwedenBio’s latest report of the Swedish pharmaceutical industry for 2016 the organization highlighted development projects within women’s health. Among the 17 projects mentioned was Redwood Pharma’s development project RP101 for the treatment of chronic dry eye disease in post-menopausal women. Attending conferences continues. Redwood Pharma will participa...
redwoodpharma.com
Redwood Pharma AB appoints Ulf Björklund as Chief Medical Officer - Redwood Pharma
http://redwoodpharma.com/redwood-pharma-ab-hires-ulf-bjorklund-chief-medical-officer
Redwood Pharma AB appoints Ulf Björklund as Chief Medical Officer. September 20, 2016. Ulf will serve to complement our firm with his unique experience and knowledge within clinical development. He joins Redwood Pharma at an exciting time in the company’s stage of growth. The recruitment of a CMO with Ulf’s background is another significant step in the development of Redwood PHrama and we are very enthusiastic that Ulf has decided to help develop our eye therapies. Says CEO Martin Vidaeus. Redwood Pharma...
redwoodpharma.com
Redwood Pharmas IntelliGel drug delivery platform demonstrates positive results in in vitro test - Redwood Pharma
http://redwoodpharma.com/redwood-pharmas-intelligel-drug-delivery-platform-demonstrates-positive-results-vitro-test
Redwood Pharmas IntelliGel drug delivery platform demonstrates positive results in in vitro test. October 7, 2016. Results from the EpiOcular tests confirm that IntelliGel can become a safe, effective and widely used drug delivery platform for the controlled release of active substances on the eye’s surface. Redwood Pharma’s RP101 development project can become the first ophthalmic pharmaceutical therapy to take advantage of the IntelliGel drug delivery platform. Says CEO Martin Vidaeus.
redwoodpharma.com
Redwood Pharma AB (publ) to present at Aktiespararna conference in Örebro on November 19, 2016 - Redwood Pharma
http://redwoodpharma.com/redwood-pharma-ab-publ-present-aktiespararna-conference-orebro-november-19-2016
Redwood Pharma AB (publ) to present at Aktiespararna conference in Örebro on November 19, 2016. November 8, 2016. On Saturday, November 19 Redwood Pharma AB will present at the conference Inspirationsträff för tjejer – Våga spara i aktier! At the City Konferenscenter, Klostergatan 23 in Örebro between 09.30 and 16.00 hrs. For more information about the conference visit:. Martin Vidaeus, CEO Redwood Pharma AB (publ.). Tel: 46 (0) 70 232 29 29. E-mail: martin.vidaeus@redwoodpharma.se. New US patent approved.
analystgroup.se
Analyst Group | Bolag - Analyst Group
http://analystgroup.se/bolag
Nedan är en sammanfattning av de bolag Analyst Group har analyserat:. Gripen Oil & Gas. Nordic Camping & Resort. Please leave this field empty. AG Equity Research AB Riddargatan 35 114 57 Stockholm Tel: 46 736 87 21 83 Email: info@analystgroup.se. AG Equity Research AB 2016 Interna Regler and Ansvarsbegränsning.
